Revealing the Truth about AI: Safeguarding Humanity in an Age of Automation

The Many Talents of Dr. Joy Buolamwini: Activism, AI Research, Art and Government Advocacy

Dr. Joy Buolamwini is a prominent figure in the world of technology, art, and activism. As the founder of the Algorithmic Justice League, she has made significant contributions to the field of AI research. Her book, Unmasking AI: My Mission to Protect What Is Human in a World of Machines, has become a national bestseller.

Dr. Joy is a trusted advisor to world leaders on issues related to preventing harm caused by AI technologies. Her groundbreaking research on facial recognition technologies has reshaped the field of AI auditing, garnering attention in over 40 countries. Her influential paper, “Gender Shades,” is among the most cited peer-reviewed publications on AI ethics. With a TED Talk that has been viewed over 1.7 million times, Dr. Joy has raised awareness about algorithmic bias and its implications.

In addition to her research, Dr. Joy actively participates in governmental discussions and congressional hearings aimed at creating equitable and accountable AI policies. She is known as the Poet of Code and uses art to shed light on the societal impacts of AI. Her artwork has been showcased on four continents, while her writing has been featured in major publications such as TIME, New York Times, Harvard Business Review, Rolling Stone, and The Atlantic.

Dr. Joy’s accolades include being named the recipient of the Technological Innovation Award from the Martin Luther King Jr. Center and the NAACP-Archewell Foundation Digital Civil Rights Award

Leave a Reply

Revenue surpasses projections while earnings per share falls short Previous post Tactile Systems Technology: Q1 2024 Financial Report Highlights Revenue Growth, Losses Per Share
Spero Therapeutics Announces First Quarter 2024 Financial Results and Business Update Date Next post Spero Therapeutics: Revolutionizing Drug Development with Promising Treatments for Rare Diseases and Multi-Drug Resistant Infections